Literature DB >> 10228830

Evaluation of major hepatic resection for small hepatocellular carcinoma.

M Shimada1, T Gion, T Hamatsu, Y Yamashita, H Hasegawa, T Utsunomiya, K Takenaka, K Sugimachi.   

Abstract

BACKGROUND/AIMS: The aim of this study is to clarify the significance of a major hepatectomy for small hepatocellular carcinomas (HCCs).
METHODOLOGY: Seventy-eight patients with solitary HCC measuring less than 3 cm in diameter, whose liver function was considered sufficient to tolerate a right hepatic lobectomy, were classified into 2 groups consisting of: a major group (n = 18), who underwent a major hepatectomy (2 segments or more); and, a minor group (n = 60), who underwent a hepatectomy including one segment or less. The early post-operative outcome and the long-term outcomes, comprising patient survival as well as disease-free survival, were compared. In addition, the post-operative long-term changes in liver function tests and esophageal variceal occurrence were also compared.
RESULTS: In the post-operative mortality and morbidity, no significant differences were found between the 2 groups. However, 1 patient in the major group unexpectedly died of liver failure 6 months after operation. No significant difference was observed in patient survival and disease-free survival. The platelet count in the major group tended to decline more rapidly than that in the minor group. Furthermore, 1 patient in the major group demonstrated risky esophageal varices 29 months after operation, which had to be treated by endoscopic injection sclerotherapy.
CONCLUSIONS: Based on the above findings, a major hepatectomy is therefore not recommended for patients with solitary small HCC measuring 3 cm or less in diameter.

Entities:  

Mesh:

Year:  1999        PMID: 10228830

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

Review 1.  Survival after anatomic resection versus nonanatomic resection for hepatocellular carcinoma: a meta-analysis.

Authors:  Jinggui Chen; Kai Huang; Jianghong Wu; Huiyan Zhu; Yingqiang Shi; Yanong Wang; Guangfa Zhao
Journal:  Dig Dis Sci       Date:  2010-11-17       Impact factor: 3.199

2.  Improvement of long-term outcomes in hepatitis C virus antibody-positive patients with hepatocellular carcinoma after hepatectomy in the modern era.

Authors:  Ken Shirabe; Kazuki Takeishi; Akinobu Taketomi; Hideaki Uchiyama; Hiroto Kayashima; Yoshihiko Maehara
Journal:  World J Surg       Date:  2011-05       Impact factor: 3.352

Review 3.  The prognostic significance of clinical and pathological features in hepatocellular carcinoma.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

4.  Systematic Reviews and Meta-Analyses of Portal Vein Embolization, Associated Liver Partition and Portal Vein Ligation, and Radiation Lobectomy Outcomes in Hepatocellular Carcinoma Patients.

Authors:  Resmi A Charalel; Jeffrey Sung; Gulce Askin; Jonathan Jo; Maria Mitry; Caroline Chung; Lyubov Tmanova; David C Madoff
Journal:  Curr Oncol Rep       Date:  2021-10-30       Impact factor: 5.075

5.  Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy.

Authors:  Li Zhou; Jing-An Rui; Shao-Bin Wang; Shu-Guang Chen; Qiang Qu; Tian-Yi Chi; Xue Wei; Kai Han; Ning Zhang; Hai-Tao Zhao
Journal:  World J Surg       Date:  2007-09       Impact factor: 3.352

6.  Portal vein embolization before right hepatectomy: prospective clinical trial.

Authors:  Olivier Farges; Jacques Belghiti; Reza Kianmanesh; Jean Marc Regimbeau; Roberto Santoro; Valérie Vilgrain; Alban Denys; Alain Sauvanet
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

Review 7.  Clinical manifestations and enzymatic activities of mitochondrial respiratory chain complexes in Pearson marrow-pancreas syndrome with 3-methylglutaconic aciduria: a case report and literature review.

Authors:  Takeshi Sato; Koji Muroya; Junko Hanakawa; Reiko Iwano; Yumi Asakura; Yukichi Tanaka; Kei Murayama; Akira Ohtake; Tomonobu Hasegawa; Masanori Adachi
Journal:  Eur J Pediatr       Date:  2015-06-16       Impact factor: 3.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.